Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)
Clinical trial NCT03301506 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03301506
- Sponsor
- Gilead Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-12
- Primary completion
- 2028-11-01
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.